{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:03:11Z","timestamp":1789635791270,"version":"4.0.0"},"reference-count":139,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"\u201cPioneer\u201d and \u201cLeading Goose\u201d R&D Program of Zhejiang","award":["2025C02176"],"award-info":[{"award-number":["2025C02176"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Gastric cancer (GC) remains one of the leading causes of cancer-related mortality worldwide. Among its defining hallmarks, metabolic reprogramming, particularly aerobic glycolysis (the Warburg effect), emerged as a central driver of tumor progression, therapeutic resistance, and immune evasion. Over the past decades, substantial efforts have delineated the molecular architecture of metabolic reprogramming in GC, identifying key effector enzymes, including hexokinase 2 (HK2), pyruvate kinase M2 (PKM2), and lactate dehydrogenase A (LDHA), as well as upstream oncogenic signaling axes, such as the PI3K\/AKT\/mTOR pathway and hypoxia-inducible factor 1-alpha (HIF-1\u03b1), along with their interconnected regulatory networks. Despite extensive preclinical validation of these nodes, clinical translation remains elusive, with glycolysis-targeted monotherapies showing limited efficacy in early-phase trials. Yet, we contend that this persistent translational failure does not stem from invalid targets, but rather from a systemic underestimation of three fundamental roadblocks: (1) temporal metabolic plasticity that enables rapid compensatory adaptation and pathway switching; (2) spatial inter- and intra-tumoral metabolic heterogeneity that undermines uniform treatment strategies; and (3) a critical void in predictive and pharmacodynamic biomarkers essential for patient stratification and treatment monitoring. To overcome these barriers, we propose an integrated, forward-looking strategic framework that converges advanced diagnostics with next-generation therapeutic modalities. On the diagnostic front, we highlight spatial multi-omics for high-resolution metabolic cartography and artificial intelligence-driven integrative patient stratification to map heterogeneity and predict treatment response. On the therapeutic front, we examine strategies designed to circumvent metabolic plasticity, including dual-pathway inhibition, nodal targeting, exploitation of non-catalytic vulnerabilities, and tumor-penetrating nanocarriers for targeted metabolic intervention. Particular emphasis is placed on rational, mechanism-driven combination regimens, especially those synergizing glycolysis-targeted therapies with immunotherapy to remodel the suppressive tumor microenvironment\u2014as well as hierarchical and parallel pathway combinations and the emerging metabolism\u2013epigenetics axis, exemplified by lactate-mediated histone lactylation and \u03b1-ketoglutarate-dependent DNA demethylation. By shifting the therapeutic paradigm from static inhibition of single metabolic nodes toward dynamic, network-level intervention, this review provides a strategic roadmap for translating the vulnerabilities inherent in the glycolytic network into durable clinical benefit for patients with GC. This paradigm shift, we argue, is essential for advancing precision metabolic medicine beyond the current impasse.<\/jats:p>","DOI":"10.3390\/cells15181679","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:03:17Z","timestamp":1789632197000},"page":"1679","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting Glycolytic Reprogramming in Gastric Cancer: Navigating the Translational Maze from Mechanism to Clinic"],"prefix":"10.3390","volume":"15","author":[{"given":"Guibing","family":"Meng","sequence":"first","affiliation":[{"name":"Jinhua Academy of Zhejiang Chinese Medical University, Jinhua 321000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Li","sequence":"additional","affiliation":[{"name":"Jinhua Academy of Zhejiang Chinese Medical University, Jinhua 321000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Gan","sequence":"additional","affiliation":[{"name":"Jinhua Academy of Zhejiang Chinese Medical University, Jinhua 321000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[{"name":"Jinhua Academy of Zhejiang Chinese Medical University, Jinhua 321000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitao","family":"Chen","sequence":"additional","affiliation":[{"name":"Jinhua Academy of Zhejiang Chinese Medical University, Jinhua 321000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"ref_1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","first-page":"101003","article-title":"Trends of gastric cancer burdens attributable to risk factors in China from 2000 to 2050","volume":"44","author":"He","year":"2024","journal-title":"Lancet Reg. Health West. Pac."},{"key":"ref_3","first-page":"47","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","year":"2024","journal-title":"J. Natl. Cancer Cent."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"v38","DOI":"10.1093\/annonc\/mdw350","article-title":"Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Smyth","year":"2016","journal-title":"Ann. Oncol."},{"key":"ref_5","first-page":"1653","article-title":"Perioperative Durvalumab in Gastric Cancer","volume":"393","author":"Hoeppner","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"104015","DOI":"10.4251\/wjgo.v17.i6.104015","article-title":"Minimally invasive lymphadenectomy for gastric cancer: Could the robotic approach provide any benefits than laparoscopy?","volume":"17","author":"Marrelli","year":"2025","journal-title":"World J. Gastrointest. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"eaaw5473","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg Effect: How Does it Benefit Cancer Cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.2147\/OTT.S189687","article-title":"Metabolic reprogramming results in abnormal glycolysis in gastric cancer: A review","volume":"12","author":"Liu","year":"2019","journal-title":"OncoTargets Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12935-023-03162-8","article-title":"Glucose transporter 3 (GLUT3) promotes lactylation modifications by regulating lactate dehydrogenase A (LDHA) in gastric cancer","volume":"23","author":"Yang","year":"2023","journal-title":"Cancer Cell Int."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejphar.2018.12.035","article-title":"Alpha-enolase promotes gastric cancer cell proliferation and metastasis via regulating AKT signaling pathway","volume":"845","author":"Sun","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Jiao, F., Wang, Z., Yuan, J., Shi, F., and Zhang, S. (2026). The tumor microenvironment shapes gastric cancer progression by coordinating immune suppression and metabolic reprogramming. Front. Immunol., 17.","DOI":"10.3389\/fimmu.2026.1787060"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s12094-023-03278-3","article-title":"Energy metabolism: A new target for gastric cancer treatment","volume":"26","author":"Liu","year":"2023","journal-title":"Clin. Transl. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s41568-018-0074-8","article-title":"mTOR signalling and cellular metabolism are mutual determinants in cancer","volume":"18","author":"Mossmann","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Zhao, M., Wei, F., Sun, G., Wen, Y., Xiang, J., Su, F., Zhan, L., Nian, Q., Chen, Y., and Zeng, J. (2022). Natural compounds targeting glycolysis as promising therapeutics for gastric cancer: A review. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.1004383"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1007\/s10620-024-08568-6","article-title":"Fructose-1, 6-Bisphosphate Aldolase B Suppresses Glycolysis and Tumor Progression of gastric cancer","volume":"69","author":"Wu","year":"2024","journal-title":"Dig. Dis. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2174\/1568009622666220413083534","article-title":"Progress in Metabolic Studies of gastric cancer and Therapeutic Implications","volume":"22","year":"2022","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"111075","DOI":"10.1016\/j.biopha.2020.111075","article-title":"N6-methyladenosine (m6A) methyltransferase WTAP accelerates the Warburg effect of gastric cancer through regulating HK2 stability","volume":"133","author":"Yu","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s12935-023-03169-1","article-title":"The emerging role of glycolysis and immune evasion in gastric cancer","volume":"23","author":"Zheng","year":"2023","journal-title":"Cancer Cell Int."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Shan, Z., and Liu, Y. (2025). Harnessing glycolysis in gastric cancer: Molecular targets, therapeutic strategies, and clinical horizons. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1628937"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41419-025-07923-3","article-title":"NLRP12 decreases TRIM25-mediated HK2 degradation to promote glycolysis and H3K18la in gastric cancer","volume":"16","author":"Zhou","year":"2025","journal-title":"Cell Death Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12935-020-01275-y","article-title":"SALL4 promotes gastric cancer progression via hexokinase II mediated glycolysis","volume":"20","author":"Shao","year":"2020","journal-title":"Cancer Cell Int."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Garcia-Martinez, E., Lino-Silva, L.S., Romo-Perez, A., Bornstein-Quevedo, L., Chavez-Blanco, A., Dominguez-Gomez, G., Lopez-Basave, H.N., Padilla-Rosciano, A., Diaz-Romero, C., and Gonzalez-Fierro, A. (2026). Expression of Hexokinase-2 (HK2), Glutaminase-1 (GLS1) and Fatty Acid Synthase (FASN) in Gastric Cancer and Their Prognostic Significance. Med. Sci., 14.","DOI":"10.3390\/medsci14010148"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00018-024-05491-x","article-title":"Helicobacter pylori promotes gastric cancer progression by activating the TGF-\u03b2\/Smad2\/EMT pathway through HKDC1","volume":"81","author":"Fang","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/cas.15692","article-title":"HKDC1 upregulation promotes glycolysis and disease progression, and confers chemoresistance onto gastric cancer","volume":"114","author":"Wang","year":"2023","journal-title":"Cancer Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"790","DOI":"10.21037\/tcr-20-2597","article-title":"Rab25 acts as an oncogene and participates in the regulation of aerobic glycolysis via PKM2 in gastric adenocarcinoma","volume":"10","author":"Zheng","year":"2021","journal-title":"Transl. Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1007\/s12033-023-00778-z","article-title":"KAT2A Promotes the Succinylation of PKM2 to Inhibit its Activity and Accelerate Glycolysis of Gastric Cancer","volume":"66","author":"Zhang","year":"2024","journal-title":"Mol. Biotechnol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.cell.2012.07.018","article-title":"PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis","volume":"150","author":"Yang","year":"2012","journal-title":"Cell"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"16082","DOI":"10.1038\/srep16082","article-title":"Nuclear PKM2 contributes to gefitinib resistance via upregulation of STAT3 activation in colorectal cancer","volume":"5","author":"Li","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"111846","DOI":"10.1016\/j.yexcr.2020.111846","article-title":"Lactic acid promotes macrophage polarization through MCT-HIF1\u03b1 signaling in gastric cancer","volume":"388","author":"Zhang","year":"2020","journal-title":"Exp. Cell Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"111462","DOI":"10.1016\/j.cellsig.2024.111462","article-title":"CAF-secreted LOX promotes PD-L1 expression via histone Lactylation and regulates tumor EMT through TGF\u03b2\/IGF1 signaling in gastric cancer","volume":"124","author":"Li","year":"2024","journal-title":"Cell. Signal."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s13046-025-03543-z","article-title":"SENP1 drives glycolysis and cisplatin resistance in gastric cancer via desumoylating ENO1","volume":"44","author":"Fang","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41392-025-02451-0","article-title":"Alpha-enolase influences ATP pool of cytoplasmand lactate homeostasis by regulating glycolysis in gastric cancer","volume":"10","author":"Shu","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41420-024-01903-w","article-title":"Hypoxia and low-glucose environments co-induced HGDILnc1 promote glycolysis and angiogenesis","volume":"10","author":"Zhang","year":"2024","journal-title":"Cell Death Discov."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s41419-025-08015-y","article-title":"TRIM8-dependent K63-ubiquitinated PGK1 promotes glycolysis and angiogenesis in gastric cancer via interaction with ACAT1","volume":"16","author":"Feng","year":"2025","journal-title":"Cell Death Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.7150\/ijbs.97091","article-title":"TRIM50 inhibits glycolysis and the malignant progression of gastric cancer by ubiquitinating PGK1","volume":"20","author":"Gu","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.molcel.2016.02.009","article-title":"Mitochondria-Translocated PGK1 Functions as a Protein Kinase to Coordinate Glycolysis and the TCA Cycle in Tumorigenesis","volume":"61","author":"Li","year":"2016","journal-title":"Mol. Cell"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"20190003","DOI":"10.1515\/pp-2019-0003","article-title":"Resistance to anoikis in transcoelomic shedding: The role of glycolytic enzymes","volume":"4","author":"Wilson","year":"2019","journal-title":"Pleura Peritoneum"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Liu, B., Zhang, Y., and Suo, J. (2021). Increased Expression of PDK4 Was Displayed in gastric cancer and Exhibited an Association with Glucose Metabolism. Front. Genet., 12.","DOI":"10.3389\/fgene.2021.689585"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.7150\/jca.83456","article-title":"ALDOB plays a tumor-suppressive role by inhibiting AKT activation in gastric cancer","volume":"14","author":"Peng","year":"2023","journal-title":"J. Cancer"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"6099","DOI":"10.2147\/OTT.S110203","article-title":"Downregulation of ALDOB is associated with poor prognosis of patients with gastric cancer","volume":"9","author":"He","year":"2016","journal-title":"OncoTargets Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3876342","DOI":"10.1155\/2023\/3876342","article-title":"HKDC1 Silencing Inhibits Proliferation and Glycolysis of Gastric Cancer Cells","volume":"2023","author":"Yu","year":"2023","journal-title":"J. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s41419-025-07997-z","article-title":"The regulatory and synergistic effects of FBP2 and HKDC1 on glucose metabolism and malignant progression in gastric cancer","volume":"16","author":"Yu","year":"2025","journal-title":"Cell Death Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3892\/ijmm.2026.5763","article-title":"Helicobacter pylori and hyperglycemia fuel gastric cancer glycolysis: Mechanisms and targeted intervention (Review)","volume":"57","author":"Liu","year":"2026","journal-title":"Int. J. Mol. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.chembiol.2012.07.021","article-title":"Small molecule activation of PKM2 in cancer cells induces serine auxotrophy","volume":"19","author":"Kung","year":"2012","journal-title":"Chem. Biol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Urbanska, K., and Orzechowski, A. (2019). Unappreciated Role of LDHA and LDHB to Control Apoptosis and Autophagy in Tumor Cells. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20092085"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"106553","DOI":"10.1016\/j.phrs.2022.106553","article-title":"Biological impact and therapeutic perspective of targeting PI3K\/Akt signaling in hepatocellular carcinoma: Promises and Challenges","volume":"187","author":"Paskeh","year":"2023","journal-title":"Pharmacol. Res."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Dong, J., Li, W., Ma, L., Yang, J., Gan, D., Xue, H., Pu, L., Zhang, L., Zhang, K., and Jia, Y. (2025). Advances in glycolysis research in gastric cancer: Molecular mechanisms, regulatory networks, and therapeutic potential. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1678681"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s13402-023-00821-w","article-title":"MAOA suppresses the growth of gastric cancer by interacting with NDRG1 and regulating the Warburg effect through the PI3K\/AKT\/mTOR pathway","volume":"46","author":"Wang","year":"2023","journal-title":"Cell Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Canales, J., Valenzuela, M., Bravo, J., Cerda-Opazo, P., Jorquera, C., Toledo, H., Bravo, D., and Quest, A.F. (2017). Helicobacter pylori Induced Phosphatidylinositol-3-OH Kinase\/mTOR Activation Increases Hypoxia Inducible Factor-1\u03b1 to Promote Loss of Cyclin D1 and G0\/G1 Cell Cycle Arrest in Human Gastric Cells. Front. Cell. Infect. Microbiol., 7.","DOI":"10.3389\/fcimb.2017.00092"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"78365","DOI":"10.18632\/oncotarget.18695","article-title":"Regulation of SIRT3 signal related metabolic reprogramming in gastric cancer by Helicobacter pylori oncoprotein CagA","volume":"8","author":"Lee","year":"2017","journal-title":"Oncotarget"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"10145","DOI":"10.2147\/CMAR.S223473","article-title":"HIF1\u03b1\/miR-520a-3p\/AKT1\/mTOR Feedback Promotes the Proliferation and Glycolysis of Gastric Cancer Cells","volume":"11","author":"Pan","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Li, N., Tang, B., Jia, Y.P., Zhu, P., Zhuang, Y., Fang, Y., Li, Q., Wang, K., Zhang, W.J., and Guo, G. (2017). Helicobacter pylori CagA Protein Negatively Regulates Autophagy and Promotes Inflammatory Response via c-Met-PI3K\/Akt-mTOR Signaling Pathway. Front. Cell. Infect. Microbiol., 7.","DOI":"10.3389\/fcimb.2017.00417"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2263936","DOI":"10.1080\/19490976.2023.2263936","article-title":"Targeting hypoxia-inducible factor-1 alpha suppresses Helicobacter pylori-induced gastric injury via attenuation of both cag-mediated microbial virulence and proinflammatory host responses","volume":"15","author":"Noto","year":"2023","journal-title":"Gut Microbes"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s11658-025-00723-9","article-title":"IGF2BP2: An m6A reader that affects cellular function and disease progression","volume":"30","author":"Liu","year":"2025","journal-title":"Cell Mol. Biol. Lett."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Zhang, Q., Liu, X., Chen, Y., Wang, R., Zhao, S., Tian, Y., Li, S., and Liu, X. (2025). IGF2BP2 regulates gastric cancer radiotherapy resistance through HIF1\u03b1-mediated glycolysis. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1512177"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/s41420-021-00674-y","article-title":"m6A reader IGF2BP2-stabilized CASC9 accelerates glioblastoma aerobic glycolysis by enhancing HK2 mRNA stability","volume":"7","author":"Liu","year":"2021","journal-title":"Cell Death Discov."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Qiao, J., Yu, Z., Zhou, H., Wang, W., Wu, H., and Ye, J. (2025). The pentose phosphate pathway: From mechanisms to implications for gastrointestinal cancers. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26020610"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e1600200","DOI":"10.1126\/sciadv.1600200","article-title":"Fundamentals of cancer metabolism","volume":"2","author":"DeBerardinis","year":"2016","journal-title":"Sci. Adv."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.biochi.2024.01.018","article-title":"Should the standard model of cellular energy metabolism be reconsidered? Possible coupling between the pentose phosphate pathway, glycolysis and extra-mitochondrial oxidative phosphorylation","volume":"221","author":"Morelli","year":"2024","journal-title":"Biochimie"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10120-023-01437-7","article-title":"N6-methyladenosine modification of OIP5-AS1 promotes glycolysis, tumorigenesis, and metastasis of gastric cancer by inhibiting Trim21-mediated hnRNPA1 ubiquitination and degradation","volume":"27","author":"Xie","year":"2023","journal-title":"Gastric Cancer"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.biopha.2017.11.015","article-title":"LINC00152\/miR-139-5p regulates gastric cancer cell aerobic glycolysis by targeting PRKAA1","volume":"97","author":"Sun","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e34658","DOI":"10.1016\/j.heliyon.2024.e34658","article-title":"CircRNAs: A promising target for intervention regarding glycolysis in gastric cancer","volume":"10","author":"Dai","year":"2024","journal-title":"Heliyon"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/kjm2.12399","article-title":"Knockdown of ZNF479 inhibits proliferation and glycolysis of gastric cancer cells through regulating \u03b2-catenin\/c-Myc signaling pathway","volume":"37","author":"Jin","year":"2021","journal-title":"Kaohsiung J. Med. Sci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"19003","DOI":"10.1038\/s41598-024-69435-y","article-title":"Gypenoside inhibits gastric cancer proliferation by suppressing glycolysis via the Hippo pathway","volume":"14","author":"Pan","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Karagil, S., Haddad, N., Stolinski, M., Hill, N., Johnson, D., Wehida, N., and Elbediwy, A. (2025). The Regulation of the Hippo Signalling Pathway Effector YAP Through a Novel Lipid-Dependent Extracellular Matrix Complex. Cells, 14.","DOI":"10.3390\/cells14211701"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4161\/15384047.2014.987021","article-title":"AMPK\/mTOR-mediated inhibition of survivin partly contributes to metformin-induced apoptosis in human gastric cancer cell","volume":"16","author":"Han","year":"2014","journal-title":"Cancer Biol. Ther."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"101945","DOI":"10.1016\/j.tranon.2024.101945","article-title":"Metformin as anticancer agent and adjuvant in cancer combination therapy: Current progress and future prospect","volume":"44","author":"Zhu","year":"2024","journal-title":"Transl. Oncol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1186\/s12967-025-07326-0","article-title":"HOXA9 drives lymphatic metastasis by activating the c-MYC-glycolysis-lactate axis in gastric cancer","volume":"23","author":"Lu","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41568-025-00800-3","article-title":"Moonlighting functions of glucose metabolic enzymes and metabolites in cancer","volume":"25","author":"Guo","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1038\/onc.2016.410","article-title":"Non-metabolic functions of glycolytic enzymes in tumorigenesis","volume":"36","author":"Yu","year":"2017","journal-title":"Oncogene"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1016\/j.molcel.2021.08.031","article-title":"Moonlighting functions of metabolic enzymes and metabolites in cancer","volume":"81","author":"Pan","year":"2021","journal-title":"Mol. Cell"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s13402-025-01135-9","article-title":"The moonlighting functions of glycolytic enzymes in tumorigenesis","volume":"49","author":"Chen","year":"2026","journal-title":"Cell Oncol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.tibs.2016.05.013","article-title":"Metabolic Enzymes Moonlighting in the Nucleus: Metabolic Regulation of Gene Transcription","volume":"41","author":"Boukouris","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0065-6","article-title":"Non-canonical functions of enzymes facilitate cross-talk between cell metabolic and regulatory pathways","volume":"50","author":"Snaebjornsson","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/ncb2629","article-title":"ERK1\/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect","volume":"14","author":"Yang","year":"2012","journal-title":"Nat. Cell Biol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e37263","DOI":"10.1016\/j.heliyon.2024.e37263","article-title":"Induction, growth, drug resistance, and metastasis: A comprehensive summary of the relationship between STAT3 and gastric cancer","volume":"10","author":"Chen","year":"2024","journal-title":"Heliyon"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/ncb1268","article-title":"S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding","volume":"7","author":"Hara","year":"2005","journal-title":"Nat. Cell Biol."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Lin, C., Yu, M., Wu, X., Wang, H., Wei, M., and Zhang, L. (2024). Targeting Moonlighting Enzymes in Cancer. Molecules, 29.","DOI":"10.3390\/molecules29071573"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.tibs.2018.01.006","article-title":"Metabolic Kinases Moonlighting as Protein Kinases","volume":"43","author":"Lu","year":"2018","journal-title":"Trends Biochem. Sci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature23275","article-title":"Fructose-1,6-bisphosphate and aldolase mediate glucose sensing by AMPK","volume":"548","author":"Zhang","year":"2017","journal-title":"Nature"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3892\/ijo.2026.5869","article-title":"Enolase 1: A paradigm of metabolic enzyme moonlighting in tumorigenesis (Review)","volume":"68","author":"Ni","year":"2026","journal-title":"Int. J. Oncol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"101076","DOI":"10.1016\/j.neo.2024.101076","article-title":"The role of glycolysis in tumorigenesis: From biological aspects to therapeutic opportunities","volume":"58","author":"Cordani","year":"2024","journal-title":"Neoplasia"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"6595","DOI":"10.2147\/IJGM.S552315","article-title":"Research Progress on the Regulation of Glycolysis in Gastric Cancer: Key Genes and Enzymes","volume":"18","author":"Chen","year":"2025","journal-title":"Int. J. Gen. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"179","DOI":"10.11648\/j.wjph.20251002.20","article-title":"Review: The Multifaceted Roles of Lactate in Gastric Cancer and Its Therapeutic Potential","volume":"10","author":"Wenyue","year":"2025","journal-title":"World J. Public Health"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Zhang, X., Li, Y., and Chen, Y. (2023). Development of a Comprehensive Gene Signature Linking Hypoxia, Glycolysis, Lactylation, and Metabolomic Insights in Gastric Cancer through the Integration of Bulk and Single-Cell RNA-Seq Data. Biomedicines, 11.","DOI":"10.3390\/biomedicines11112948"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1186\/s40001-025-03383-9","article-title":"Lactate and gastric cancer immunotherapy from regulatory mechanisms to therapeutic strategies: A critical review","volume":"30","author":"Hao","year":"2025","journal-title":"Eur. J. Med. Res."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Yang, H., Zou, X., Yang, S., Zhang, A., Li, N., and Ma, Z. (2023). Identification of lactylation related model to predict prognostic, tumor infiltrating immunocytes and response of immunotherapy in gastric cancer. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1149989"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1038\/s42255-022-00708-4","article-title":"Metabolic enzyme LDHA activates Rac1 GTPase as a noncanonical mechanism to promote cancer","volume":"4","author":"Liu","year":"2022","journal-title":"Nat. Metab."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41388-024-03243-6","article-title":"Delactylase effects of SIRT1 on a positive feedback loop involving the H19-glycolysis-histone lactylation in gastric cancer","volume":"44","author":"Tsukihara","year":"2025","journal-title":"Oncogene"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.tig.2021.09.009","article-title":"Histone lactylation: Epigenetic mark of glycolytic switch","volume":"38","author":"Dai","year":"2022","journal-title":"Trends Genet."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"104630","DOI":"10.1016\/j.isci.2022.104630","article-title":"Identification of lysine-lactylated substrates in gastric cancer cells","volume":"25","author":"Yang","year":"2022","journal-title":"iScience"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Yang, H., Chen, R., Zheng, X., Luo, Y., Yao, M., Ke, F., Guo, X., Liu, X., and Liu, Q. (2025). Cooperative Role of Carbonic Anhydrase IX\/XII in Driving Tumor Invasion and Metastasis: A Novel Targeted Therapeutic Strategy. Cells, 14.","DOI":"10.3390\/cells14100693"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1002\/pros.21172","article-title":"Targeting tumor metabolism with 2-deoxyglucose in patients with castrate-resistant prostate cancer and advanced malignancies","volume":"70","author":"Stein","year":"2010","journal-title":"Prostate"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"CT206","DOI":"10.1158\/1538-7445.AM2015-CT206","article-title":"Abstract CT206: PFK-158, first-in-man and first-in-class inhibitor of PFKFB3\/glycolysis: A phase I, dose escalation, multi-center study in patients with advanced solid malignancies","volume":"75","author":"Redman","year":"2015","journal-title":"Cancer Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"TPS2606","DOI":"10.1200\/jco.2015.33.15_suppl.tps2606","article-title":"A phase I, dose-escalation, multi-center study of PFK-158 in patients with advanced solid malignancies explores a first-in-man inhbibitor of glycolysis","volume":"33","author":"Redman","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_97","first-page":"33","article-title":"Lonidamine versus high-dose tamoxifen in progressive, advanced renal cell carcinoma: Results of an ongoing randomized phase II study","volume":"18","author":"Stahl","year":"1991","journal-title":"Semin. Oncol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0360-3016(94)90225-9","article-title":"Double-blind randomized study of lonidamine and radiotherapy in head and neck cancer","volume":"29","author":"Magno","year":"1994","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10637-015-0221-y","article-title":"A phase I open-labeled, single-arm, dose-escalation, study of dichloroacetate (DCA) in patients with advanced solid tumors","volume":"33","author":"Chu","year":"2015","journal-title":"Investig. New Drugs"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1023\/A:1010686204736","article-title":"Oral gossypol in the treatment of patients with refractory metastatic breast cancer: A phase I\/II clinical trial","volume":"66","author":"Seidman","year":"2001","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"The Cancer Genome Atlas Research Network (2014). Comprehensive molecular characterization of gastric adenocarcinoma. Nature, 513, 202\u2013209.","DOI":"10.1038\/nature13480"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s10142-020-00753-w","article-title":"Occurrence of differing metabolic dysregulations, a glucose driven and another fatty acid centric in gastric cancer subtypes","volume":"20","author":"Balakrishnan","year":"2020","journal-title":"Funct. Integr. Genom."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1158\/1078-0432.CCR-24-3473","article-title":"Clinical Implications of the Cancer Genome Atlas Molecular Classification System in Esophagogastric Cancer","volume":"31","author":"Walch","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ccell.2018.12.003","article-title":"Proteogenomic Characterization of Human Early-Onset gastric Cancer","volume":"35","author":"Mun","year":"2019","journal-title":"Cancer Cell"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth","volume":"41","author":"Joyce","year":"2023","journal-title":"Cancer Cell"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Xu, L., Liu, J., An, Y., Zhou, L., Sun, H., Xu, Z., Wang, D., Liang, Z., Xu, C., and Wang, B. (2024). Glycolysis-related genes predict prognosis and indicate immune microenvironment features in gastric cancer. BMC Cancer, 24.","DOI":"10.1186\/s12885-024-12747-z"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cmet.2020.06.019","article-title":"Mitochondrial Metabolism as a Target for Cancer Therapy","volume":"32","author":"Vasan","year":"2020","journal-title":"Cell Metab."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1158\/1078-0432.CCR-17-3070","article-title":"Oxidative Phosphorylation as an Emerging Target in Cancer Therapy","volume":"24","author":"Ashton","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Aisu, Y., Oshima, N., Hyodo, F., Elhelaly, A.E., Masuo, A., Okada, T., Hisamori, S., Tsunoda, S., Hida, K., and Morimoto, T. (2024). Dual inhibition of oxidative phosphorylation and glycolysis exerts a synergistic antitumor effect on colorectal and gastric cancer by creating energy depletion and preventing metabolic switch. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0309700"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Ara, H., Subedi, U., Sharma, P., Bhattarai, S., Sharma, S., Manikandan, S., Yu, X., Bhuiyan, M.S., Sun, H., and Miriyala, S. (2022). Alteration of Cellular Energy Metabolism through LPAR2-Axin2 Axis in Gastric Cancer. Biomolecules, 12.","DOI":"10.3390\/biom12121805"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"112185","DOI":"10.1016\/j.celrep.2023.112185","article-title":"NF-\u03baB activation enhances STING signaling by altering microtubule-mediated STING trafficking","volume":"42","author":"Zhang","year":"2023","journal-title":"Cell Rep."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10565-024-09917-x","article-title":"Mechanisms of HIF1A-mediated immune evasion in gastric cancer and the impact on therapy resistance","volume":"40","author":"Qi","year":"2024","journal-title":"Cell Biol. Toxicol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40170-021-00244-x","article-title":"Prognostic value of metabolic tumor volume and total lesion glycolysis on preoperative 18F-FDG PET\/CT in patients with localized primary gastrointestinal stromal tumors","volume":"9","author":"Hwang","year":"2021","journal-title":"Cancer Metab."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1148\/radiol.2020203275","article-title":"Comparison of 68Ga-FAPI and 18F-FDG Uptake in Gastric, Duodenal, and Colorectal Cancers","volume":"298","author":"Pang","year":"2021","journal-title":"Radiology"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Imlimthan, S., Moon, E.S., Rathke, H., Afshar-Oromieh, A., Rosch, F., Rominger, A., and Gourni, E. (2021). New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress. Pharmaceuticals, 14.","DOI":"10.3390\/ph14101023"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Marquardt, A., Hartrampf, P., Kollmannsberger, P., Solimando, A.G., Meierjohann, S., Kubler, H., Bargou, R., Schilling, B., Serfling, S.E., and Buck, A. (2023). Predicting Microenvironment in CXCR4- and FAP-Positive Solid Tumors-A Pan-Cancer Machine Learning Workflow for Theranostic Target Structures. Cancers, 15.","DOI":"10.3390\/cancers15020392"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.7150\/thno.51797","article-title":"Cisplatin-resistant NSCLC cells induced by hypoxia transmit resistance to sensitive cells through exosomal PKM2","volume":"11","author":"Wang","year":"2021","journal-title":"Theranostics"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1111\/cas.70056","article-title":"Exosomal PKM2: A Noninvasive Diagnostic Marker Linking Macrophage Metabolic Reprogramming to Gastric Cancer Pathogenesis","volume":"116","author":"Yuan","year":"2025","journal-title":"Cancer Sci."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1038\/s41388-025-03566-y","article-title":"RAB22A triggers intercellular chemoresistance transmission in colorectal cancer by promoting exosome release via the PKM2-pSNAP23 axis","volume":"44","author":"Yin","year":"2025","journal-title":"Oncogene"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Fridman, E.S., Ginini, L., and Gil, Z. (2022). The Role of Extracellular Vesicles in Metabolic Reprogramming of the Tumor Microenvironment. Cells, 11.","DOI":"10.3390\/cells11091433"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1158\/2159-8290.CD-24-0605","article-title":"Spatially Resolved Tumor Ecosystems and Cell States in Gastric Adenocarcinoma Progression and Evolution","volume":"15","author":"Ma","year":"2025","journal-title":"Cancer Discov."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.semcancer.2022.12.009","article-title":"Artificial intelligence-based multi-omics analysis fuels cancer precision medicine","volume":"88","author":"He","year":"2023","journal-title":"Semin. Cancer Biol. Semin."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1038\/s41467-024-46043-y","article-title":"Metabolomic machine learning predictor for diagnosis and prognosis of gastric cancer","volume":"15","author":"Chen","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"108371","DOI":"10.1016\/j.pharmthera.2023.108371","article-title":"Novel strategies and promising opportunities for targeted protein degradation: An innovative therapeutic approach to overcome cancer resistance","volume":"244","author":"Zhu","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"115776","DOI":"10.1016\/j.addr.2026.115776","article-title":"Harnessing targeted protein degradation to potentiate cancer immunotherapy: From molecular mechanisms to delivery strategies","volume":"230","author":"Liu","year":"2026","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jconrel.2022.12.003","article-title":"Targeting glycolysis for cancer therapy using drug delivery systems","volume":"353","author":"Huang","year":"2023","journal-title":"J. Control. Release"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"114844","DOI":"10.1016\/j.colsurfb.2025.114844","article-title":"Advances in the design and application of glycolysis-related nanodelivery systems for anti-tumor","volume":"254","author":"Zhou","year":"2025","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.cmet.2018.02.024","article-title":"Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy","volume":"27","author":"Cascone","year":"2018","journal-title":"Cell Metab."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s10120-023-01405-1","article-title":"Gastric cancer mesenchymal stem cells via the CXCR2\/HK2\/PD-L1 pathway mediate immunosuppression","volume":"26","author":"Huang","year":"2023","journal-title":"Gastric Cancer"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1186\/s12967-025-07013-0","article-title":"CAFs promote immune evasion in gastric cancer through histone lactylation-mediated suppression of NCAPG ubiquitination","volume":"23","author":"Zhou","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"109536","DOI":"10.1016\/j.bioorg.2026.109536","article-title":"Pharmacological inhibition of histone Lactylation enhances immunotherapy efficacy in gastrointestinal cancers","volume":"170","author":"Li","year":"2026","journal-title":"Bioorg. Chem."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Ni, X., Zhang, K., Huang, X., Zhang, M., Guo, J., Fan, W., Wang, C., Du, Z., Jiang, T., and Zhang, G. (2025). Targeting PGK1 as a Novel strategy to regulate the sensitivity of HER2 positive gastric cancer to lapatinib. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1530492"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1158\/0008-5472.CAN-21-1820","article-title":"Disrupting Circadian Rhythm via the PER1-HK2 Axis Reverses Trastuzumab Resistance in Gastric Cancer","volume":"82","author":"Wang","year":"2022","journal-title":"Cancer Res."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nrc.2016.82","article-title":"Metabolic control of epigenetics in cancer","volume":"16","author":"Kinnaird","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"750","DOI":"10.21037\/jgo-24-825","article-title":"Biomarker-driven therapeutic strategies in advanced gastric cancer: A case series of curative responses","volume":"16","author":"Park","year":"2025","journal-title":"J. Gastrointest. Oncol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41420-025-02704-5","article-title":"One-carbon metabolic pathway is a novel molecular signature for CD44-positive intestinal-type gastric cancer","volume":"11","author":"Joo","year":"2025","journal-title":"Cell Death Discov."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12943-025-02328-4","article-title":"The application of organoids in investigating immune evasion in the microenvironment of gastric cancer and screening novel drug candidates","volume":"24","author":"Kan","year":"2025","journal-title":"Mol. Cancer"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Lv, Z., Yang, R., Liu, L., Shi, X., Wang, R., Wu, J., and Jiao, J. (2025). Lactylation as a cross-regulatory node in tumor metabolism and epigenetics: Insights and therapeutic implications. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1675480"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/18\/1679\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:22:43Z","timestamp":1789633363000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/18\/1679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":139,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["cells15181679"],"URL":"https:\/\/doi.org\/10.3390\/cells15181679","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]}}}